Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.

Passildas J, Paillard MJ, Uwer L, Molnar I, Dohollou N, Petit T, Hajjaji N, Boudin L, Lorgis V, Jacquin JP, Abrial C, Mouret-Reynier MA

Open source

DOI: 10.1016/j.canep.2025.102800
Published: 2025 Jun
Container: Cancer epidemiology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.canep.2025.102800,
  title = {Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.},
  author = {Passildas J and Paillard MJ and Uwer L and Molnar I and Dohollou N and Petit T and Hajjaji N and Boudin L and Lorgis V and Jacquin JP and Abrial C and Mouret-Reynier MA},
  year = {2025},
  journal = {Cancer epidemiology},
  doi = {10.1016/j.canep.2025.102800},
  url = {https://doi.org/10.1016/j.canep.2025.102800}
}

RIS

TY  - JOUR
TI  - Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.
AU  - Passildas J
AU  - Paillard MJ
AU  - Uwer L
AU  - Molnar I
AU  - Dohollou N
AU  - Petit T
AU  - Hajjaji N
AU  - Boudin L
AU  - Lorgis V
AU  - Jacquin JP
AU  - Abrial C
AU  - Mouret-Reynier MA
PY  - 2025
JO  - Cancer epidemiology
DO  - 10.1016/j.canep.2025.102800
UR  - https://doi.org/10.1016/j.canep.2025.102800
ER  -

APA

J, P., MJ, P., L, U., I, M., N, D., T, P., N, H., L, B., V, L., JP, J., C, A., & MA, M. (2025). Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.. Cancer epidemiology. https://doi.org/10.1016/j.canep.2025.102800

Source records

pubmed · retrieved 2026-09-27T11:25:07.642Z